迟发性皮肤卟啉症
医学
米利亚
皮肤病科
多毛症
色素沉着
结缔组织病
羟基氯喹
吗啡
卟啉
全身性疾病
结缔组织病
外科
病理
疾病
自身免疫性疾病
硬化性苔藓
2019年冠状病毒病(COVID-19)
传染病(医学专业)
作者
Timothy Nyckowski,Alexandra Grammenos,Alisa Vinokurov,Rajiv Nathoo
标识
DOI:10.1080/09546634.2022.2060925
摘要
Porphyria cutanea tarda (PCT), the most common porphyria, is a rare photodermatosis characterized by fragile, hemorrhagic bullae and erosions with associated milia, hyperpigmentation, and hypertrichosis. SLE is a systemic connective tissue disease with approximately 80% of those affected manifesting cutaneous findings. These include malar and discoid rashes, photosensitivity, bullae, oral ulcerations, as well as a variety of other nonspecific findings. In this case, we illustrate a rare but established association between these two pathologic entities, and the resulting therapeutic challenge in treating a patient with both conditions. The concurrence of these two diseases poses therapeutic challenges with a paucity of evidence-based recommendations. Management with low dose weekly antimalarial therapy may be the appropriate middle ground in effectively treating the two co-morbid conditions especially in a patient with other underlying systemic conditions.
科研通智能强力驱动
Strongly Powered by AbleSci AI